Over-the-counter drugs for minor sore throats suggested warning.ĭrugs with thyroid hormone activity for human use required warning.ĭigitalis and related cardiotonic drugs for human use in oral dosage forms required warning.
Labeling of drug preparations containing salicylates. Magnesium sulfate heptahydrate label declaration on drug products. Phenindione labeling of drug preparations intended for use by man. Ipecac syrup warnings and directions for use for over-the-counter sale.Īcetophenetidin (phenacetin)-containing preparations necessary warning statement. Sodium phosphates package size limitation, warnings, and directions for over-the-counter sale. Potassium salt preparations intended for oral ingestion by man. Isoproterenol inhalation preparations (pressurized aerosols, nebulizers, powders) for human use warnings. Tannic acid and barium enema preparations. Labeling of drug preparations containing significant proportions of wintergreen oil. Notice to manufacturers, packers, and distributors of drugs for internal use which contain mineral oil. Notice to manufacturers, packers, and distributors of estrogenic hormone preparations. Notice to manufacturers, packers, and distributors of glandular preparations. Specific Labeling Requirements for Specific Drug Products Labeling Claims for Drugs in Drug Efficacy Studyĭisclosure of drug efficacy study evaluations in labeling and advertising. Prescription chemicals and other prescription components.ĭrugs for processing, repacking, or manufacturing.ĭrugs for use in teaching, law enforcement, research, and analysis.ĭrugs exemption for radioactive drugs for research use.ĭrugs processing, labeling, or repacking. Specific requirements on content and format of labeling for human prescription drug and biological products older drugs not described in § 201.56(b)(1).Įxemptions From Adequate Directions for Use Labeling Requirements for Over-the-Counter Drugsįormat and content requirements for over-the-counter (OTC) drug product labeling. Specific requirements on content and format of labeling for human prescription drug and biological products described in § 201.56(b)(1). Requirements on content and format of labeling for human prescription drug and biological products. Labeling Requirements for Prescription Drugs and/or Insulin Labeling for systemic antibacterial drug products.Įxceptions or alternatives to labeling requirements for human drug products held by the Strategic National Stockpile. Prescription drugs containing sulfites required warning statements. 6 in certain drugs for human use.ĭeclaration of presence of phenylalanine as a component of aspartame in over-the-counter and prescription drugs for human use.
4 PICS 1 WORD ANSWERS 6 LETTERS LEVEL 503 ANSWER 7 CODE
Drugs name and place of business of manufacturer, packer, or distributor.ĭrugs and devices National Drug Code numbers.ĭrugs prominence of required label statements.ĭrugs Spanish-language version of certain required statements.ĭeclaration of presence of FD&C Yellow No.
0 kommentar(er)
